Changes in gait following continuous intrathecal baclofen infusion in ambulant children and young adults with cerebral palsy

References

• SCPE Collaborative Group. Prevalence and characteristics of children with cerebral palsy in Europe. Developmental Medicine in Child Neurology 2002; 44: 633–640
   PubMedGoogle Scholar
• Krigger K. Cerebral palsy: An overview. American Family Physician 2006; 73: 91–100, 101–102
   PubMed Web of Science ®Google Scholar
• Butler C, Campbell S. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACPDM Treatment Outcomes Committee Review Panel. Developmental Medicine in Child Neurology 2000; 42: 634–645
   PubMed Web of Science ®Google Scholar
• Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. Journal of the American Medical Association 1993; 270: 2475–2477
   PubMed Web of Science ®Google Scholar
• Van Schaeybroeck P, Nuttin B, Lagae L, Schrijvers E, Borghgraef C, Feys P. Intrathecal baclofen for intractable cerebral spasticity: A prospective placebo-controlled, double-blind study. Neurosurgery 2000; 46: 603–609
   PubMed Web of Science ®Google Scholar
• Murphy NA, Irwin MC, Hoff C. Intrathecal baclofen therapy in children with cerebral palsy: Efficacy and complications. Archives of Physical Medicine and Rehabilitation 2002; 83: 1721–1725
   PubMed Web of Science ®Google Scholar
• Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML. Care provider assessment of intrathecal baclofen in children. Developmental Medicine in Child Neurology 2004; 46: 548–552
   PubMedGoogle Scholar
• Fitzgerald JJ, Tsegaye M, Vloeberghs MH. Treatment of childhood spasticity of cerebral origin with intrathecal baclofen: A series of 52 cases. British Journal of Neurosurgery 2004; 18: 240–245
   PubMed Web of Science ®Google Scholar
• Krach LE, Kriel RL, Gilmartin RC, Swift DM, Storrs BB, Abbott R, Ward JD, Bloom KK, Brooks WH, Madsen JR, et al. GMFM 1 year after continuous intrathecal baclofen infusion. Pediatric Rehabilitation 2005; 8: 207–213
   PubMedGoogle Scholar
• Gerszten PC, Albright AL, Barry MJ. Effect on ambulation of continuous intrathecal baclofen infusion. Pediatric Neurosurgery 1997; 27: 40–44
   Google Scholar
• Bleyenheuft C, Filipetti P, Caldas C, Lejeune T. Experience with external pump trial prior to implantation for intrathecal baclofen in ambulatory patients with spastic cerebral palsy. Neurophysiologie Clinique 2007; 37: 23–28
   PubMedGoogle Scholar
• Brochard S, Remy-Neris O, Filipetti P, Bussel B. Intrathecal baclofen infusion for ambulant children with cerebral palsy. Pediatric Neurology 2009; 40: 265–270
   PubMed Web of Science ®Google Scholar
• Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental Medicine in Child Neurology 1997; 39: 214–223
   PubMed Web of Science ®Google Scholar
• Ashworth B. Preliminary trial of carisoprodal in multiple sclerosis. Practitioner 1964; 192: 540–542
   PubMedGoogle Scholar
• Rodda J, Graham H, Carson L, Galea M, Wolfe R. Sagittal gait patterns in spastic diplegia. Journal of Bone and Joint Surgery 2004; 86-B: 251–258
   Google Scholar
• Novacheck T, Stout J, Tervo R. Reliability and validity of the Gillette Functional Assessment Questionnaire as an outcome measure in children with walking disabilities. Journal of Pediatric Orthopaedics 2000; 20: 75–79
   PubMed Web of Science ®Google Scholar
• Davis R, Ounpuu S, Tybursky D, Gage J. A gait analysis data collection and reduction technique. Human Movement Science 1991; 10: 575–587
   Web of Science ®Google Scholar
• Benedetti MG, Catani F, Leardini A, Pignotti E, Giannini S. Data management in gait analysis for clinical applications. Clinical Biomechanics (Bristol, Avon) 1998; 13: 204–215
   PubMed Web of Science ®Google Scholar
• Schutte LM, Narayanan U, Stout JL, Selber P, Gage JR, Schwartz MH. An index for quantifying deviations from normal gait. Gait and Posture 2000; 11: 25–31
   PubMed Web of Science ®Google Scholar
• Trost JP, Schwartz MH, Krach LE, Dunn ME, Novacheck TF. Comprehensive short-term outcome assessment of selective dorsal rhizotomy. Developmental Medicine in Child Neurology 2008; 50: 765–771
   PubMed Web of Science ®Google Scholar
• Subramanian N, Vaughan C, Peter J, Arens L. Gait before and ten years after rhizotomy in children with cerebral palsy spasticity. Journal of Neurosurgery 1998; 88: 1014–1019
   PubMedGoogle Scholar
• Steinbok P. Outcomes after selective dorsal rhizotomy for spastic cerebral palsy. Childs Nervous System 2001; 17: 1–18
   PubMed Web of Science ®Google Scholar
• Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Hadley MN. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy. Archives of Physical Medicine and Rehabilitation 2001; 82: 155–161
   PubMed Web of Science ®Google Scholar
• Campbell WM, Ferrel A, McLaughlin JF, Grant GA, Loeser JD, Graubert C, Bjornson K. Long-term safety and efficacy of continuous intrathecal baclofen. Developmental Medicine in Child Neurology 2002; 44: 660–665
   PubMedGoogle Scholar
• Sgouros S, Seri S. The effect of intrathecal baclofen on muscle co-contraction in children with spasticity of cerebral origin. Pediatric Neurosurgery 2002; 37: 225–230
   PubMedGoogle Scholar
• Bottos M, Feliciangeli A, Sciuto L, Gericke C, Vianello A. Functionnal status of adults with cerebral palsy and implications for treatment of children. Developmental Medicine in Child Neurology 2001; 43: 516–528
   PubMed Web of Science ®Google Scholar
• Johnson D, Damiano DL, Abel MF. The evolution of gait in childhood and adolescent cerebral palsy. Journal of Pediatric Orthopaedics 1997; 17: 392–396
   PubMed Web of Science ®Google Scholar